Stock Market Forum

Clear all

Is China's Vaccine leader, 6185, worth watching?  

Patrick McLoughlin
Posts: 6
Joined: 11 months ago

INO, Moderna, and Novavax might come to mind. However, CaSino Biologics produced positive phase I results last month for their COVID-19 treatment. Some scientists criticised the results because its still early stages. However, China, just like the rest of the world, need the virus to disappear for both health and economic reasons. Is the hype of CaSino's upcoming phase II trial worth riding or just another loose end?